Skip to main content

Table 10 Result of the solution stability study of DOX

From: A stability-indicating HPLC method for estimation of doxylamine succinate in tablets and characterization of its major alkaline stress degradation product

Sr. no

Time

Amount of drug estimated DOX*

% Label claim

S. D. (±)

C. V.

1

30 min

24.70

98.82

0.619

0.623

2

1 h

24.98

99.92

0.346

0.350

3

2 h

25.00

100.0

0.424

0.427

4

4 h

24.75

99.00

0.537

0.541

5

8 h

24.88

99.52

0.801

0.804

6

24 h

25.25

101.0

0.599

0.603

  1. *Average of three determinations